{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:51:56Z","timestamp":1790941916226,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":232,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003202","name":"North American Spine Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001279","name":"Orthopaedic Research and Education Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.wneu.2023.02.064","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T04:24:40Z","timestamp":1676867080000},"page":"e26-e34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Can We Use Artificial Intelligence Cluster Analysis to Identify Patients with Metastatic Breast Cancer to the Spine at Highest Risk of Postoperative Adverse Events?"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5886-546X","authenticated-orcid":false,"given":"Mitchell S.","family":"Fourman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Duvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2058-9556","authenticated-orcid":false,"given":"Duncan C.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-2514","authenticated-orcid":false,"given":"Rafael","family":"De La Garza Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamed","family":"Hadzipasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh M.","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Schoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yassari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Massaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7490-8108","authenticated-orcid":false,"given":"John H.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2023.02.064_bib1","doi-asserted-by":"crossref","first-page":"E671","DOI":"10.1093\/neuros\/nyz070","article-title":"Predicting 90-day and 1-year mortality in spinal metastatic disease: development and internal validation","volume":"85","author":"Karhade","year":"2019","journal-title":"Clin Neurosurg"},{"key":"10.1016\/j.wneu.2023.02.064_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/BSD.0000000000001031","article-title":"Scoring algorithms for predicting survival prognosis in patients with metastatic spinal disease: the current status and future directions","volume":"33","author":"Cui","year":"2020","journal-title":"Clin Spine Surg"},{"key":"10.1016\/j.wneu.2023.02.064_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.14245\/ns.1938402.201","article-title":"Predictive analytics in spine oncology research: first steps, limitations, and future directions","volume":"16","author":"Massaad","year":"2019","journal-title":"Neurospine"},{"key":"10.1016\/j.wneu.2023.02.064_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jocn.2021.09.031","article-title":"Comparison of three predictive scoring systems for morbidity in oncological spine surgery","volume":"94","author":"De la Garza Ramos","year":"2021","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2023.02.064_bib5","first-page":"1","article-title":"Evaluating frailty, mortality, and complications associated with metastatic spine tumor surgery using machine learning-derived body composition analysis","author":"Massaad","year":"2022","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.wneu.2023.02.064_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.spinee.2018.05.037","article-title":"Complications and reoperations after surgery for 647 patients with spine metastatic disease","volume":"19","author":"Paulino Pereira","year":"2019","journal-title":"Spine J"},{"key":"10.1016\/j.wneu.2023.02.064_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ejcts\/ezx215","article-title":"The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices","volume":"53","author":"Yang","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.wneu.2023.02.064_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.spinee.2015.09.043","article-title":"Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS)","volume":"16","author":"Schoenfeld","year":"2016","journal-title":"Spine J"},{"key":"10.1016\/j.wneu.2023.02.064_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00586-016-4921-6","article-title":"The revised Tokuhashi score; analysis of parameters and assessment of its accuracy in determining survival in patients afflicted with spinal metastasis","volume":"27","author":"Aoude","year":"2018","journal-title":"Eur Spine J"},{"key":"10.1016\/j.wneu.2023.02.064_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2021.2.FOCUS201113","article-title":"Performance assessment of the metastatic spinal tumor frailty index using machine learning algorithms: limitations and future directions","volume":"50","author":"Massaad","year":"2021","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2023.02.064_bib11","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","article-title":"A\u00a0novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the spine oncology study group","volume":"35","author":"Fisher","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.wneu.2023.02.064_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","article-title":"Reliability analysis of the epidural spinal cord compression scale","volume":"13","author":"Bilsky","year":"2010","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.wneu.2023.02.064_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/BRS.0000000000004139","article-title":"Characterizing Health-related quality of life by ambulatory status in patients with spinal metastases","volume":"47","author":"Schoenfeld","year":"2022","journal-title":"Spine"},{"key":"10.1016\/j.wneu.2023.02.064_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3340\/jkns.2011.50.3.216","article-title":"Postoperative survival and ambulatory outcome in metastatic spinal tumors: prognostic factor analysis","volume":"50","author":"Moon","year":"2011","journal-title":"J\u00a0Korean Neurosurg Soc"},{"key":"10.1016\/j.wneu.2023.02.064_bib15","doi-asserted-by":"crossref","first-page":"E798","DOI":"10.1097\/BRS.0b013e3182927559","article-title":"Pre- and postoperative lower extremity motor power and ambulatory status of patients with spinal cord compression due to a metastatic spinal tumor","volume":"38","author":"Park","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.wneu.2023.02.064_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1158\/1055-9965.EPI-17-0627","article-title":"Differences in breast cancer survival by molecular subtypes in the United States","volume":"27","author":"Howlader","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.wneu.2023.02.064_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10585-017-9871-9","article-title":"De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype","volume":"34","author":"Press","year":"2017","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.wneu.2023.02.064_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2016.12.015","article-title":"Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis","volume":"74","author":"Leone","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.wneu.2023.02.064_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/annonc\/mdq688","article-title":"Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancer","volume":"22","author":"Zurrida","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.wneu.2023.02.064_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clbc.2015.03.010","article-title":"Hormone receptor status and HER2 expression in primary breast cancer compared with synchronous axillary metastases or recurrent metastatic disease","volume":"15","author":"Rossi","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.wneu.2023.02.064_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2013.10.004","article-title":"A\u00a0meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases","volume":"50","author":"Aurilio","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.wneu.2023.02.064_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/annonc\/mds248","article-title":"Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis","volume":"24","author":"Dieci","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.wneu.2023.02.064_bib23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1055\/s-0035-1564807","article-title":"A\u00a0systematic review of clinical outcomes and prognostic factors for patients undergoing surgery for spinal metastases secondary to breast cancer","volume":"6","author":"Sciubba","year":"2016","journal-title":"Global Spine J"},{"key":"10.1016\/j.wneu.2023.02.064_bib24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00586-007-0380-4","article-title":"Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease","volume":"16","author":"Sciubba","year":"2007","journal-title":"Eur Spine J"},{"key":"10.1016\/j.wneu.2023.02.064_bib25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/os.12551","article-title":"Patient characteristics following surgery for spinal metastases: a multicenter retrospective study","volume":"11","author":"Yang","year":"2019","journal-title":"Orthop Surg"},{"key":"10.1016\/j.wneu.2023.02.064_bib26","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1007\/s00586-016-4406-7","article-title":"The timing of surgical intervention in the treatment of complete motor paralysis in patients with spinal metastasis","volume":"25","author":"Fan","year":"2016","journal-title":"Eur Spine J"},{"key":"10.1016\/j.wneu.2023.02.064_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.annonc.2020.12.013","article-title":"Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL","volume":"32","author":"Martin","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.wneu.2023.02.064_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1470-2045(19)30804-6","article-title":"CDK4\/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis","volume":"21","author":"Gao","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.wneu.2023.02.064_bib29","first-page":"CD013538","article-title":"Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer","volume":"3","author":"Bui","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.wneu.2023.02.064_bib30","doi-asserted-by":"crossref","first-page":"11046","DOI":"10.3390\/ijms231911046","article-title":"Current molecular combination therapies used for the treatment of breast cancer","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.wneu.2023.02.064_bib31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2023.02.064_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/fon-2020-0464","article-title":"Alpelisib in the treatment of metastatic HR+ breast cancer with PIK3CA mutations","volume":"17","author":"Mavratzas","year":"2021","journal-title":"Future Oncol"},{"key":"10.1016\/j.wneu.2023.02.064_bib33","first-page":"CD002747","article-title":"Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer","volume":"2003","author":"Wilcken","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.wneu.2023.02.064_bib34","first-page":"202","article-title":"Updates in endocrine therapy for metastatic breast cancer","volume":"19","author":"Manohar","year":"2021","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.wneu.2023.02.064_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2020.01.003","volume":"98","author":"Woo","year":"2020","journal-title":"Hum Pathol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875023002139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875023002139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T05:42:39Z","timestamp":1717738959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875023002139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":35,"alternative-id":["S1878875023002139"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2023.02.064","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can We Use Artificial Intelligence Cluster Analysis to Identify Patients with Metastatic Breast Cancer to the Spine at Highest Risk of Postoperative Adverse Events?","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2023.02.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}